Montag & Associates’s Celgene Corp CELG Stock Holding History

Montag & Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,776	Closed	-$498K	–	305
2017 Q4	$498K	Sell	4,776 -2,825	-37%	-$319K	0.05%	213
2017 Q3	$1.11M	Buy	+7,601	New	+$1.04M	0.12%	149

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Montag & Associates's CELG Position: Q1 2018 in Review

Montag & Associates sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 4,776 shares — an estimated $498K sold.

Montag & Associates first reported a position in CELG in Q3 2017 and held it in 2 quarters. The position peaked at $1.11M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Montag & Associates reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Montag & Associates sold 4,776 Celgene Corp shares in Q1 2018, an estimated $498K.
Montag & Associates first reported a position in Celgene Corp in Q3 2017 and held it in 2 quarters.
Montag & Associates's Celgene Corp position peaked at $1.11M in Q3 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Montag & Associates's 13F filing for Q1 2018, filed 7 May 2018.